Medyssey Co (XKRX:200580) EPS (Basic): ₩910.00 (TTM As of Dec. 2025)


XKRX:200580 Medyssey Co Ltd XKRX:200580
88 GF Score
Price ₩11,990.00
GF Value ₩12,300.33
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Medyssey Co EPS (Basic)?

Medyssey Co XKRX:200580 88 EPS (Basic) is ₩910.00 as of Dec. 2025. GuruFocus rates XKRX:200580 with a GF Score™ of 88/100 and a GF Value™ of ₩12,300.33 (Fairly Valued). The stock has 2 warning signs investors should review.

Medyssey Co's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was ₩910.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was ₩910.00.

Medyssey Co's EPS (Diluted) for the six months ended in Dec. 2025 was ₩910.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was ₩910.00.

Medyssey Co's EPS without NRI for the six months ended in Dec. 2025 was ₩960.70. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 960.70.

During the past 12 months, Medyssey Co's average EPS without NRIGrowth Rate was 32.60% per year. During the past 3 years, the average EPS without NRI Growth Rate was -2.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was 20.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 10 years, Medyssey Co's highest 3-Year average EPS without NRI Growth Rate was 103.50% per year. The lowest was -14.60% per year. And the median was 42.40% per year.

Medyssey Co  (XKRX:200580) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Medyssey Co EPS (Basic) Related Terms

Medyssey Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Medyssey Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medyssey Co EPS (Basic) Chart

Medyssey Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,364.00 1,210.00 655.00 669.00 910.00

Medyssey Co Semi-Annual Data
Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,364.00 1,210.00 655.00 669.00 910.00
XKRX:200580
88GF Score
Medyssey Co Ltd XKRX:200580
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medyssey Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Medyssey Co's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(3328.325-0)/3.658
=909.88

Medyssey Co's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(3328.325-0)/3.658
=909.88

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was ₩910.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₩910.00 mean?
Medyssey Co (XKRX:200580) has a EPS (Basic) of ₩910.00 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Medyssey Co and its competitors.
Is Medyssey Co's EPS (Basic) too high?
Medyssey Co's current EPS (Basic) is ₩910.00. Overall, Medyssey Co has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medyssey Co's EPS (Basic) compare to ABT and SYK?
Medyssey Co's EPS (Basic) of ₩910.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Medyssey Co and its competitors. Medyssey Co's current EPS (Basic) is ₩910.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medyssey Co stock overvalued right now?
Based on GuruFocus' analysis, Medyssey Co (XKRX:200580) is currently considered Fairly Valued. The stock's GF Value™ is ₩12,300.33, compared to a current price of ₩11,990.00 — trading 2.5% below its estimated fair value. The current EPS (Basic) is ₩910.00. Medyssey Co's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Medyssey Co (XKRX:200580), the current EPS (Basic) is ₩910.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medyssey Co (XKRX:200580) Overvalued in 2026?

Based on GuruFocus' analysis, Medyssey Co stock appears to be undervalued. The current stock price of ₩11,990.00 is trading 2.5% below its estimated GF Value™ of ₩12,300.33. GuruFocus considers Medyssey Co to be Fairly Valued.

Key valuation signals for XKRX:200580:

  • EPS (Basic): ₩910.00
  • GF Value™: ₩12,300.33 vs. price of ₩11,990.00 (2.5% below fair value)
  • GF Score™: 88/100 with 2 warning signs

No single metric tells the full story. See the XKRX:200580 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medyssey Co Business Description

Address 129, Hanbang Expo-ro, Wangam-dong, Chungcheongbuk-do, Jecheon-si, KOR, 27116
Medyssey Co Ltd designs, develops, manufactures and markets products for the surgical treatment of spine disorders. The main products of the company include spinal implants used in surgeries to treat spinal instability caused by spinal degeneration, stenosis, external trauma, or tumors, and spinal fusions for the treatment of congenital and acquired spinal deformities and scoliosis.
88GF Score

Get the complete analysis for XKRX:200580

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩11,990.00
Price
₩12,300.33
GF Value